Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT04921345 · COMPLETED
Trial details
- NCT number
- NCT04921345
- Sponsor
- Galderma R&D
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-24
- Primary completion
- 2025-04-28
- Enrollment
- 109
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.